These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20638992)
1. The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity. Wójcicka G; Jamroz-Wiśniewska A; Marciniak A; Łowicka E; Bełtowski J Life Sci; 2010 Jul; 87(3-4):126-32. PubMed ID: 20638992 [TBL] [Abstract][Full Text] [Related]
2. The paraoxonase 1 (PON1), platelet-activating factor acetylohydrolase (PAF-AH) and dimethylarginine dimethylaminohydrolase (DDAH) activity in the metformin treated normal and diabetic rats. Wójcicka G; Jamroz-Wiśniewska A; Czechowska G; Korolczuk A; Marciniak S; Bełtowski J Eur J Pharmacol; 2016 Oct; 789():187-194. PubMed ID: 27450486 [TBL] [Abstract][Full Text] [Related]
3. Antidiabetic effect of alcoholic extract of Caralluma sinaica L. on streptozotocin-induced diabetic rabbits. Habibuddin M; Daghriri HA; Humaira T; Al Qahtani MS; Hefzi AA J Ethnopharmacol; 2008 May; 117(2):215-20. PubMed ID: 18359177 [TBL] [Abstract][Full Text] [Related]
4. Effects of cod liver oil on tissue antioxidant pathways in normal and streptozotocin-diabetic rats. Hünkar T; Aktan F; Ceylan A; Karasu C; Cell Biochem Funct; 2002 Dec; 20(4):297-302. PubMed ID: 12415563 [TBL] [Abstract][Full Text] [Related]
5. Increased glutathione levels and activity of PON1 (phenyl acetate esterase) in the liver of rats after a single dose of cyclophosphamide: a defense mechanism? Abraham P; Sugumar E Exp Toxicol Pathol; 2008 Mar; 59(5):301-6. PubMed ID: 18032000 [TBL] [Abstract][Full Text] [Related]
6. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia. Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466 [TBL] [Abstract][Full Text] [Related]
7. The influence of glimepiride on the oxidative state of rats with streptozotocin-induced hyperglycemia. Krauss H; Koźlik J; Grzymisławski M; Sosnowski P; Mikrut K; Piatek J; Paluszak J Med Sci Monit; 2003 Nov; 9(11):BR389-93. PubMed ID: 14586267 [TBL] [Abstract][Full Text] [Related]
8. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis. Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488 [TBL] [Abstract][Full Text] [Related]
9. [Effects of glibenclamide on mRNA level of ATP-sensitive potassium channels of heart in normal and streptozotocin-induced diabetic rats]. Li Y; Deng Q; Fu Z Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):538-40. PubMed ID: 11798815 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. Yilmaz HR; Uz E; Yucel N; Altuntas I; Ozcelik N J Biochem Mol Toxicol; 2004; 18(4):234-8. PubMed ID: 15452882 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of conventional sulfonylureas and glimepiride. Geisen K; Végh A; Krause E; Papp JG Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987 [TBL] [Abstract][Full Text] [Related]
12. Effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities. Bełtowski J; Wójcicka G; Jamroz A J Cardiovasc Pharmacol; 2004 Jan; 43(1):121-7. PubMed ID: 14668577 [TBL] [Abstract][Full Text] [Related]
13. Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats. Ao Y; Chen J; Yue J; Peng RX Eur J Pharmacol; 2008 Jun; 587(1-3):330-5. PubMed ID: 18462715 [TBL] [Abstract][Full Text] [Related]
14. Serum platelet-activating factor acetylhydrolase and paraoxonase-1 activity in horses infected with Leptospira spp. Turk R; Habuš J; Flegar-Meštrić Z; Svetina A; Mojčec V; Perkov S; Belić M; Starešina V; Turk N Acta Trop; 2011 May; 118(2):97-100. PubMed ID: 21414286 [TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: a comparison study with combination treatment. Zobali F; Avci A; Canbolat O; Karasu C Cell Biochem Funct; 2002 Jun; 20(2):75-80. PubMed ID: 11979500 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome. Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305 [TBL] [Abstract][Full Text] [Related]
17. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Bełtowski J; Wójcicka G; Jamroz A Atherosclerosis; 2003 Sep; 170(1):21-9. PubMed ID: 12957679 [TBL] [Abstract][Full Text] [Related]
18. Hypolipidemic effects of acute and sub-chronic administration of an aqueous extract of Ajuga iva L. whole plant in normal and diabetic rats. El-Hilaly J; Tahraoui A; Israili ZH; Lyoussi B J Ethnopharmacol; 2006 May; 105(3):441-8. PubMed ID: 16417981 [TBL] [Abstract][Full Text] [Related]
19. Hypoglycaemic and hypolipidaemic effects of fractions from kolaviron, a biflavonoid complex from Garcinia Kola in streptozotocin-induced diabetes mellitus rats. Adaramoye OA; Adeyemi EO J Pharm Pharmacol; 2006 Jan; 58(1):121-8. PubMed ID: 16393472 [TBL] [Abstract][Full Text] [Related]
20. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin. Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]